< Back to situations

We’ll email you as it develops, and you can follow the whole thread from day one.

[SITUATION] · [QUIET]

2 clusters · 8 sources · 29 days · First seen · Last updated

Category: BUSINESS

Brazil pharmaceutical expansion

Entities: IQVIA · Marcelo Grasso · ALKO do Brasil · Blau Farmacêutica · Dennys Santos

Overview

In early July, Brazilian drugmakers EMS and FarmaUSA announced large‑scale capacity upgrades, signalling a push to increase manufacturing output. By month‑end, Rio de Janeiro‑based ALKO do Brasil prepared to launch its first prescription‑only medical‑cannabis product, targeting thousands of units in hundreds of pharmacies, while the pharmacy federation Fecofar reported rapid growth of its dermocosmetics program across multiple networks.

Later in July, ALKO refined its rollout plan, aiming to introduce the cannabis medication between August and September, with an initial target of 5,000 units and placement in 500 pharmacy points, later expanding to 1,500 locations and pricing below the market average. Blau Farmacêutica disclosed a R$1.5 billion investment for plant upgrades, drug development and acquisitions, including certification of its Cotia facility to produce the monoclonal antibody pembrolizumab and the purchase of the Bergamo laboratory. IQVIA projected total pharmaceutical sales to reach R$24.35 billion in July, a 10.6 % year‑over‑year rise, while online pharmacy sales grew 48.7 % from 2024 to 2025, reaching R$19.56 billion (17 % of revenue). Assaí Farma opened a second São Paulo pharmacy, part of a plan for 25 stores by end‑2026, offering around 10,000 SKUs and new health services.

Claims

What the coverage asserts, and how well corroborated each claim is across sources.

Timeline

  1. 11 days ago

    [BUSINESS] 8 sources
    Brazil's pharma sector expands with cannabis launch, biotech funding and digital pharmacy growth

    Brazil's pharma sector sees a cannabis product launch by ALKO, R$1.5 bn biotech investment by Blau, a July market forecast of R$24.35 bn, 48.7% growth in online pharmacy sales, and Assaí Farma's second store.

  2. about 1 month ago

    [BUSINESS] 2 sources
    Brazil pharma firms EMS, FarmaUSA launch major capacity expansions

    EMS invests R$1 bn to expand its Manaus plant, while FarmaUSA nationalises cannabis production in Brazil, planning a new plant and product line, highlighting rapid growth in the local pharma sector.

Sources

abradilan.com.br · agenciasebrae.com.br · jornalempresasenegocios.com.br · nkfu.com · panoramafarmaceutico.com.br · politifake.com · revistapegn.globo.com · sart.org

This summary has been updated 1 time: see revision history